tiprankstipranks
Trending News
More News >
Soleno Therapeutics Inc (SLNO)
NASDAQ:SLNO
US Market
Advertisement

Soleno Therapeutics (SLNO) Ownership - Who Owns Soleno Therapeutics?

Compare
862 Followers

Soleno Therapeutics (SLNO) Ownership Overview

10.06%25.37%0.02%10.89%53.66%
10.06% Insiders
0.02% Other Institutional Investors
10.89% ETFs
53.66% Public Companies and
Individual Investors
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 36.27% of the company’s stock is owned by Institutional Investors, 10.06% is owned by Insiders, and 53.66% is owned by Public Companies and Individual Investors.
The ownership structure of Soleno Therapeutics (SLNO) stock is a mix of institutional, retail, and individual investors. Approximately 25.38% of the company’s stock is owned by Institutional Investors, 10.06% is owned by Insiders, and 10.89% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 31, 2025
xxxxxxxxxxxxx
$424792
Mar 31, 2025
xxxxxxxxxxxxx
$2480110
Mar 31, 2025
xxxxxxxxxxxxx
$700300
Mar 31, 2025
xxxxxxxxxxxxx
$4883085

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2025
xxxxxxxxxxxxx
$8436478
Jun 30, 2025
xxxxxxxxxxxxx
$32194391
Jun 30, 2025
xxxxxxxxxxxxx
$36062179

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,458,294Insider8.39%301,692,755
2,217,060Institution4.17%150,028,450
2,000,979Institution3.77%135,406,249
1,561,082Institution2.94%105,638,419
1,521,963Institution2.86%102,991,236
1,332,101Institution2.51%90,143,275
1,331,801Institution2.51%90,122,974
1,123,087Institution2.11%75,999,297
778,800Institution1.47%52,701,396
652,100Institution1.23%44,127,607

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
2,000,979Institution3.77%135,406,249
1,561,082Institution2.94%105,638,419
1,331,801Institution2.51%90,122,974
1,123,087Institution2.11%75,999,297
778,800Institution1.47%52,701,396
652,100Institution1.23%44,127,607
614,833Institution1.16%41,605,749
586,455Institution1.10%39,685,410
522,481Institution0.98%35,356,289
477,646Institution0.90%32,322,305

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
1,499,873Institution2.82%101,391,415
1,271,706Institution2.39%80,855,067
992,238Institution1.87%67,144,745
518,865Institution0.98%35,075,274
365,249Institution0.69%24,716,400
233,804Institution0.44%14,865,258
198,956Institution0.37%13,449,426
117,414Institution0.22%7,937,186
61,117Institution0.12%4,135,787
56,444Institution0.11%3,627,656

FAQ

Who Owns Soleno Therapeutics Inc (SLNO)?
According to the latest TipRanks data, approximately 0.02% of the company's stock is held by institutional investors, 10.06% is held by insiders, and 53.66% is held by retail investors.
    What percentage of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 0.02% of Soleno Therapeutics Inc (SLNO) stock is held by institutional investors.
      What percentage of Soleno Therapeutics Inc (SLNO) stock is held by retail investors?
      According to the latest TipRanks data, approximately 53.66% of Soleno Therapeutics Inc (SLNO) stock is held by retail investors.
        Who owns the most shares of Soleno Therapeutics Inc (SLNO)?
        Vivo Opportunity, LLC owns the most shares of Soleno Therapeutics Inc (SLNO).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis